- Lobbying
- Daniel AND McCarthy
Lobbying Arrangements Results for 'Daniel Mc Carthy'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details -S.1350: WIPPES Act -H.R.2964: WIPPES Act -Issues related to environmental sustainability -Asia-Pacific Economic Cooperation -US/European Relations -Latin America/US Relations -Middle East Relatio... |
The Procter and Gamble Company
|
in-house lobbying | |||
Details Aerospace to include space and satellite programs. Acquisition policy. Science programs. Spectrum - to include 5G. Data rights issues. FY24 NASA Authorization legislation. FY24 CJS Appropriations. ... |
BOEING COMPANY
|
in-house lobbying | |||
Details 2023 Farm Bill H.R.1298/S.618 US Foundation for International Conservation Act H.R.4629/S.2247 Upper Colorado and San Juan River Basins Endangered Fish Recovery Programs Reauthorization Act of 2023... |
The Nature Conservancy
|
in-house lobbying | |||
Details Fiscal Year 2024 Appropriations: Request for congressionally directed spending for multi-year workforce development demonstration pilot project integrating nurse education and practice for professi... |
OREGON HEALTH & SCIENCE UNIVERSITY
|
in-house lobbying | |||
Details 2023 Farm Bill GIPSA - Farm Fair practices rule AMS - Mandatory Price Reporting CFTC price volatility oversight Cell-Base proteins Coronavirus Food Assistance Program Commodity Credit Corporation C... |
AMERICAN FARM BUREAU FED
|
in-house lobbying | |||
Details H.R. 6363: Further Continuing Appropriation and Other Extensions Act, 2024 - 2023 Farm Bill Reauthorization; provisions related to biofuels and sustainable aviation fuels H.R. 2670: National Defens... |
EXXON MOBIL CORP
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying | |||
Details |
NEURIM PHARMACEUTICALS (1997) LTD
|
WARD & ASSOCIATES |